Bolivia signs deal with India's Serum Institute for 50L vaccine doses
The Bolivian government has signed a contract with Serum Institute of India (SII) for the supply of 50 lakh doses of AstraZeneca's COVID-19 vaccine. Bolivian President Luis Arce said the first 10 lakh AstraZeneca doses will arrive in Bolivia in April. The Drugs Controller General of India (DCGI) approved the Covishield vaccine for emergency use in India on January 3.